NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	Aditya Birla SL Pharma & Healthcare Fund - Dir (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Fund Type	Equity	Equity
Risk	Very High	Very High
Min SIP Amount	₹10	₹100
Min Lumpsum	₹1,000	₹500
Expense Ratio	1.05%	1.07%
NAV	₹41.51 (11 Nov 2026)	₹18.37 (11 Nov 2026)
Fund Size	₹1,087.96 Cr	₹964.26 Cr
Fund Started	11 Jul 2019	06 Feb 2024
Lock-in Period	No lock-in	No lock-in
Exit Load	1%For redemption / switch-out of units on or before 30 days from the date of allotment: of applicable NAV NilFor redemption / switch-out of units after 30 days from the date of allotment

Returns	Aditya Birla SL Pharma & Healthcare Fund - Dir (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
1M	7.45%	8.70%
3M	2.04%	5.33%
6M	13.18%	18.50%
1Y	21.92%	26.29%
3Y	21.21%	—
5Y	15.90%	—
Since Inception	21.34%	24.72%

Trailing risk-adjusted performance measures

Risk Ratio	Aditya Birla SL Pharma & Healthcare Fund - Dir (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Alpha	14.60	18.26
Beta	0.61	0.66
Sharpe	0.96	0.98
Standard Deviation	4.43	4.63

Holding Analysis	Aditya Birla SL Pharma & Healthcare Fund - Dir (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Top 5 Holdings	35.42%	31.19%
Top 10 Holdings	54.61%	47.59%
Portfolio Turnover	0.18	1.79
Equity	99.41%	90.72%
Debt	0.68%	8.70%
Cash	—	—

Name	Assets

Fund Manager	Aditya Birla SL Pharma & Healthcare Fund - Dir (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Name		, , , , ,

About	Aditya Birla SL Pharma & Healthcare Fund - Dir (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
AMC	Aditya Birla Sun Life Mutual Fund	WhiteOak Capital Mutual Fund
Scheme Category	Sectoral Fund	Sectoral Fund
Benchmark	BSE Healthcare TRI	BSE Healthcare TRI
Launch Date	20 Jun 2019	16 Jan 2024

Divis Laboratories LtdEquity	8.36%
Sun Pharmaceutical ...Equity	7.11%
Torrent Pharmaceuti...Equity	6.26%
C C IReverse Repo	5.55%
Laurus Labs LtdEquity	3.91%
Apollo Hospitals En...Equity	3.75%
Cipla LtdEquity	3.68%
Sai Life Sciences LtdEquity	3.28%
Ipca Laboratories LtdEquity	2.88%
Zydus Lifesciences LtdEquity	2.81%